Search
Meldonium
go.drugbank.com/drugs/DB13723InvestigationalProducts: SATURID 100 MG/ ML I.V. ENJEKSIYONLUK ÇÖZELTI IÇEREN AMPULDermatophagoides farinae
go.drugbank.com/drugs/DB10400ApprovedInvestigationalDermatophagoides farinae extracts are sterile solutions used for intradermal testing or subcutaneous immunotherapy. This combination is approved for as a year-round, once-a-day tablet that's dissolved under the tongue as a treatment for ...
Mixtures: Allergenic Extract Mixture Of Standardized Mites (5,000 Au/ml), Allergenic Extract Mixture Of Standardized Mites (15,000 Au/ml)Products: Standardized Mite, Dermatophagoides farinae, Intradermal, 300 AU per mL, Farinae -10000units/mlCerebrolysin
go.drugbank.com/drugs/DB16599InvestigationalProducts: Ambotonin 215,2 mg/ml - parenterale Lösung Injektionslösung/Konzentrat zur Herstellung einer InfusionslösungLoteprednol etabonate
go.drugbank.com/drugs/DB14596ApprovedIt is used in ophthalmic solution for the treatment of steroid responsive inflammatory conditions of the eye such as allergic conjunctivitis, uveitis, acne rosacea, superficial punctate keratitis, herpes … approved include Kala Pharmaceutical's Inveltys - the first twice-daily (BID) ocular corticosteroid approved for this indication, designed specifically to enhance patient compliance and simplified dosing compared
Mixtures: TOBRALOT 5 MG+3 MG/ML GÖZ DAMLASI, SÜSPANSİYON, 1 ADET, ZYLET OFTALMIK SUSPANSIYON, 2.5 MLProducts: LOTEMAX 5MG/ML GÖZ DAMLASI, SÜSPANSİYON, 5 ML, VISIONFREE® X 5 MLPirenoxine
go.drugbank.com/drugs/DB15945InvestigationalProducts: KARY UNI OPHTHALMIC SUSPENSION 0.05 mg/mlFimasartan
go.drugbank.com/drugs/DB09279InvestigationalFimasartan was initially approved September 9th, 2010 in South Korea and is marketed under the brand name _Kanarb_ by Boryung Pharmaceuticals. … Fimasartan is an angiotensin II receptor antagonist (ARB) drug employed in the treatment of both hypertension and heart failure.
Categories: Agents Acting on the Renin-Angiotensin SystemProducts: KANARB®PLUS FILM COATED TABLETS 60 MG/12.5 MG, KANARB®PLUS FILM COATED TABLETS 120 MG/12.5 MGBlinatumomab
go.drugbank.com/drugs/DB09052ApprovedInvestigationalMRD) greater than or equal to 0.1% in adults and children. … [L44311] Full approval for this indication was granted in June 2023.
Products: BLINCYTO® 38.5 MCG/VIAL, BLINCYTO POWDER FOR INFUSION 35 MCG/VIALPegaspargase
go.drugbank.com/drugs/DB00059ApprovedInvestigational[A255912,A255917] In February 1994, pegaspargase was approved by the FDA for the treatment of ALL in patients with hypersensitivity to native forms of L-asparaginase.[A255927] … However, leukemia cells have low levels of this enzyme and depend on exogenous sources. Therefore, the use of pegaspargase results in leukemic cell death.
Categories: Compounds used in a research, industrial, or household settingProducts: ONCASPAR® 750 U/ML POLVO PARA SOLUCIÓN INYECTABLE, ONCASPAR POWDER FOR SOLUTION FOR INJECTION/INFUSION 750 U/MLMomelotinib
go.drugbank.com/drugs/DB11763ApprovedInvestigationalMomelotinib works to block the JAK-signal transducer and activator of transcription (STAT) signalling pathway, which is aberrant in MF.[A261561, A261566, A261571] … MF includes primary MF (PMF), post-polycythemia vera (PV) MF, and post-essential thrombocythemia (ET) MF. Clinical manifestations of MF include anemia and thrombocytosis.
Synonyms: N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOANILINO)PYRIMIDIN-4-YL)BENZAMIDEPotassium acetate
go.drugbank.com/drugs/DB14498ApprovedMixtures: NUMETA PED G16 % E İNFÜZYONLUK EMÜLSİYON, 500 ML, NUTRIFLEX LIPID PLUS INFUZYONLUK EMULSIYON, 2500 MLProducts: DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 g/5 ml, Potassium Acetate Inj 2meq/ml